Chinese biotech firms eye foreign pharma's fat revenues in weight loss drug market

INSUBCONTINENT EXCLUSIVE:
When Hong Kong office worker W.K
Chang began putting on weight as a teenager, her doctor said it was due to hormonal imbalances that slowed her metabolism
She reached a peak weight of 100kg about a year ago, but has since lost 25kg. The secret to losing a quarter of her weight? Chang, who asked
not to be identified by her full name, was one of the city’s first 200 chronic obesity patients to receive access to a new weight-loss
drug, originally developed for diabetes
At a cost of HK$2,700...